MRC Epidemiology UnitProject Management Lead
Research Management
Current work and interests
In October 2023, Aisling joined the MRC Epidemiology Unit as Project Management Lead and works closely with Principal Investigators and Research Support team leads to provide project management leadership and practical support for large scale, complex or strategically important Unit projects. Aisling completed a PRINCE2 Foundation Project Management course in 2018 and an Agile Project Management Foundation & Practitioner course in 2023.
Population Health Improvement UK
Aisling is also the Strategic Project Manager for the national research network Population Health Research UK (PHI-UK).
PHI-UK has been established with a £35 million investment over four years from UK Research and Innovation (UKRI), bringing together expertise and insight from across research, public health and community organisations. Its aim is to find innovative and inclusive ways to improve the health of people, places and communities and reduce health inequalities through the development and evaluation of long-lasting and environmentally sustainable interventions.
For general PHI-UK enquiries, please email phiuk@mrc-epid.cam.ac.uk
Background and experience
Aisling received her undergraduate degree in Genetics from Trinity College Dublin and PhD from Dublin City University. She completed postdoctoral fellowships in breast cancer research at the Royal College of Surgeons in Ireland and Cancer Research UK Cambridge Institute (with Professor Jason Carroll), partially funded by an IRCSET Inspire Marie Curie Mobility Fellowship. Following this, Aisling spent two years as a Principal Scientific Associate in Dr Duncan Odom’s lab at the Cancer Research UK Cambridge Institute, analysing non-coding regions of the genome. She then became Group Research Manager with Professor Rebecca Fitzgerald at the Early Cancer Institute, a role which comprised of laboratory management, clinical study management and project management. The Fitzgerald group focus on early detection of Oesophageal cancer and pioneered the CytospongeTM technology. Aisling has been associated with Hughes Hall since 2013 and was a member of the Governing Body and other committees at various stages during this time.